Cargando…
Rapid testing for coronavirus disease 2019 (COVID-19)
Rapid testing, generally refers to the paper-based diagnostic platform known as “lateral flow assay” (LFA), has emerged as a critical asset to the containment of coronavirus disease 2019 (COVID-19) around the world. LFA technology stands out amongst peer platforms due to its cost-effective design, u...
Autores principales: | Biby, Alexander, Wang, Xiaochuan, Liu, Xinliang, Roberson, Olivia, Henry, Allya, Xia, Xiaohu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769796/ https://www.ncbi.nlm.nih.gov/pubmed/35075405 http://dx.doi.org/10.1557/s43579-021-00146-5 |
Ejemplares similares
-
Testing for anosmia and ageusia in patients presenting to the emergency department with suspected coronavirus disease 2019 in Saudi Arabia
por: Kentab, Osama Y, et al.
Publicado: (2022) -
Statistical methods for design and testing of 3D-printed polymers
por: Espino, Michaela T., et al.
Publicado: (2023) -
Rapid and label-free detection of COVID-19 using coherent anti-Stokes Raman scattering microscopy
por: Tabish, Tanveer A., et al.
Publicado: (2020) -
Epidemiological and clinical characteristics of COVID-19 patients in Hengyang, Hunan Province, China
por: Zhong, Zhe-Feng, et al.
Publicado: (2020) -
Back to the Future: Moving Beyond “Mesenchymal Stem Cells”
por: Bianco, Paolo
Publicado: (2011)